Alambic Investment Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-25,398
| Closed | -$76K | – | 24 |
|
|
2020
Q3 | $76K | Sell |
25,398
-13,661
| -35% | -$40.9K | 0.83% | 44 |
|
|
2020
Q2 | $121K | Buy |
39,059
+700
| +2% | +$2.17K | 0.3% | 123 |
|
|
2020
Q1 | $85K | Sell |
38,359
-2,811
| -7% | -$6.23K | 0.21% | 141 |
|
|
2019
Q4 | $126K | Sell |
41,170
-2,399
| -6% | -$7.34K | 0.11% | 233 |
|
|
2019
Q3 | $134K | Sell |
43,569
-161,860
| -79% | -$498K | 0.1% | 245 |
|
|
2019
Q2 | $411K | Sell |
205,429
-7,829
| -4% | -$15.7K | 0.25% | 161 |
|
|
2019
Q1 | $919K | Buy |
213,258
+77,659
| +57% | +$335K | 0.38% | 97 |
|
|
2018
Q4 | $431K | Buy |
135,599
+109,312
| +416% | +$347K | 0.18% | 178 |
|
|
2018
Q3 | $138K | Buy |
+26,287
| New | +$138K | 0.11% | 235 |
|
|
2018
Q2 | – | Sell |
-10,800
| Closed | -$54K | – | 389 |
|
|
2018
Q1 | $54K | Buy |
+10,800
| New | +$54K | 0.01% | 447 |
|